د الزایمر ناروغي د میتودونو ترکیب له لارې تشخیص کیږي ، پشمول د بشپړ طبي ارزونې ، ادراکي او نیوروپسیولوژیکي ازموینې ، د دماغ انځور کول ، او د نورو احتمالي لاملونو له مینځه وړلو پروسه.
1. طبي ارزونه: یو ډاکټر به فزیکي معاینه ترسره کړي او تفصیلي طبي تاریخ به واخلي ترڅو د حافظې له لاسه ورکولو یا ادراکي خرابیدو نور احتمالي لاملونه رد کړي ، لکه د تایرایډ ستونزې ، د ویټامین کمښت ، یا د دماغ تومورونه.
د ادراکي او عصبي رواني ازموینې: دا ازموینې حافظه ، ژبه ، د ستونزې حل کول ، او نور ادراکي دندې ارزوي ترڅو د ادراکي زیان کچه وټاکي او د عادي عمر پورې اړوند د حافظې ضایع کیدو او دماغي ناروغۍ ترمینځ توپیر وکړي.
Liu SS, Zhu SQ: [Correlation between Alzheimer disease and cataract]. Zhonghua Yan Ke Za Zhi. 2017, 53 (4): 314-316.
Gauthier S: Practical guidelines for the antemortem diagnosis of senile dementia of the Alzheimer type. Prog Neuropsychopharmacol Biol Psychiatry. 1985, 9 (5-6): 491-5.
Rubin R: New Test to Help Diagnose Alzheimer Disease. JAMA. 2022, 327 (23): 2281.
[Blood Based Biomarker for Optimization of Early and Differential Diagnosis of Alzheimer's Dementia]. Fortschr Neurol Psychiatr. 2022, 90 (7-08): 326-335.
Kapp MB: Physicians' legal duties regarding the use of genetic tests to predict and diagnose Alzheimer disease. J Leg Med. 2000, 21 (4): 445-75.
Britschgi M, Wyss-Coray T: Blood protein signature for the early diagnosis of Alzheimer disease. Arch Neurol. 2009, 66 (2): 161-5.
Volicer L, Berman SA, Cipolloni PB, Mandell A: Persistent vegetative state in Alzheimer disease. Does it exist? Arch Neurol. 1997, 54 (11): 1382-4.
Imabayashi E, Saitoh Y, Tsukamoto T, Sakata M, Takano H: Combination of Astrogliosis and Phosphorylated Tau for the Preclinical Diagnosis of Alzheimer Disease Using 3-Dimensional Stereotactic Surface Projection Images With 18 F-THK5351. Clin Nucl Med. 2022, 47 (12): 1066-1068.
Martínez A, Lahiri DK, Giacobini E, Greig NH: Advances in Alzheimer therapy: understanding pharmacological approaches to the disease. Curr Alzheimer Res. 2009, 6 (2): 83-5.
د مسؤلیت څخه ډډه: طبي
دا ویب پا onlyه یوازې د تعلیمي او معلوماتو اهدافو لپاره چمتو شوې او د طبي مشورې یا مسلکي خدماتو چمتو کولو په توګه نه ګڼل کیږي.
چمتو شوي معلومات باید د روغتیا ستونزې یا ناروغۍ تشخیص یا درملنې لپاره ونه کارول شي ، او هغه څوک چې شخصي طبي مشوره غواړي باید د جواز لرونکي ډاکټر سره مشوره وکړي.
مهرباني وکړئ په یاد ولرئ چې عصبي شبکه چې پوښتنو ته ځوابونه تولیدوي ، په ځانګړي توګه غیر دقیق دی کله چې دا د عددي مینځپانګې خبره راځي. د مثال په توګه ، د خلکو شمیر چې د ځانګړي ناروغۍ تشخیص شوی.
تل د طبي حالت په اړه د خپل ډاکټر یا بل وړ روغتیا چمتو کونکي مشوره وغواړئ. هیڅکله مسلکي طبي مشوره له پامه مه غورځوئ یا د دې په ویب پا onه کې د لوستلو له امله د دې په لټه کې ځنډ مه کوئ. که تاسو فکر کوئ چې تاسو ممکن طبي بیړنی حالت ولرئ ، سمدلاسه 911 ته زنګ ووهئ یا نږدې بیړني خونې ته لاړ شئ. د دې ویب پا orې یا کارولو لخوا د ډاکټر - ناروغ اړیکه نه رامینځته کیږي. نه بایومډلیب او نه یې کارمندان ، او نه هم د دې ویب پا toې کوم مرسته کونکی ، د دې چمتو شوي معلوماتو یا کارولو په اړه کوم څرګند یا ضمني استازیتوب کوي.
Alzheimer's disease is diagnosed through a combination of methods, including a thorough medical evaluation, cognitive and neuropsychological tests, brain imaging, and the process of elimination of other possible causes.
1. Medical evaluation: A doctor will perform a physical examination and take a detailed medical history to rule out other possible causes of memory loss or cognitive decline, such as thyroid problems, vitamin deficiencies, or brain tumors.
2. Cognitive and neuropsychological tests: These tests assess memory, language, problem-solving, and other cognitive functions to determine the extent of cognitive impairment and to differentiate between normal age-related memory loss and dementia.
3. Brain imaging: Magnetic resonance imaging (MRI) or computed tomography (CT) scans can help identify structural changes in the brain that may indicate Alzheimer's disease.
Positron emission tomography (PET) scans can also be used to measure the levels of certain proteins associated with Alzheimer's disease.
4. Blood tests: Recent research has shown that certain blood tests can help diagnose Alzheimer's disease by measuring the levels of specific proteins or biomarkers associated with the disease.
5. Process of elimination: Since there is no single definitive test for Alzheimer's disease, diagnosis often involves ruling out other possible causes of dementia-like symptoms.
It is important to note that a definitive diagnosis of Alzheimer's disease can only be made after death through an examination of brain tissue.
However, current diagnostic methods can provide a high level of certainty for a clinical diagnosis while the person is still alive.
Early diagnosis is important for starting treatment and planning for the future.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
